Petch, Jeremy
Nelson, Walter
Wu, Mary
Ghassemi, Marzyeh
Benz, Alexander
Fatemi, Mehdi
Di, Shuang
Carnicelli, Anthony
Granger, Christopher
Giugliano, Robert
Hong, Hwanhee
Patel, Manesh
Wallentin, Lars
Eikelboom, John
Connolly, Stuart J.
Funding for this research was provided by:
Core operating budget of the Center for Data Science and Digital Health at Hamilton Health Sciences
Article History
Received: 2 May 2023
Accepted: 20 February 2024
First Online: 24 February 2024
Competing interests
: Dr. Petch reports research support from Roche Canada. Mr. Nelson has nothing to disclose. Ms. Wu has nothing to disclose. Ms. Di has nothing to disclose. Dr. Carnicelli is supported by grant funding from the National Institutes of Health (5T32HL069749-17). Dr. Ghassemi has nothing to disclose. Dr. Benz has nothing to disclose. Dr. Fatemi is an employee of Microsoft Research. Dr. Granger reports research grants/contracts from AKROS, Apple, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Duke Clinical Research Institute, US Food and Drug Administration, Glaxosmithkline, Janssen Pharmaceutica, Medtronic Foundation, Novartis, and Pfizer; Consulting from Abbvie, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CeleCor Therapeutics, Correvio, Espero BioPharma, Janssen, Medscape, Medtronic LLC, Medtronic Inc, Merck, National Institute of Health, Novo Nordisk, Novartis, Pfizer, Rhoshan Pharmaceuticals, and Roche Diagnostics. Dr. Giugliano reports research support from Amgen and Anthos Therapeutics; Honoraria for CME lectures from Amgen, Daiichi Sankyo, and Servier; Consultant fees from Amarin, American College of Cardiology, Amgen, Astra Zeneca, CryoLife, CVS Caremark, Daiichi Sankyo, Esperion, Gilead, Glaxosmithkline, SAJA Pharmaceuticals, Samsung, and Servier. Dr. Hong has nothing to disclose. Dr. Patel reports receiving research grants/contracts from AstraZeneca, Bayer, and Janssen Research and Development; Funding through Duke for educational activities from AstraZeneca and Janssen Research and Development; Consulting from AstraZeneca, Bayer, and the Thrombosis Research Institute. Dr. Wallentin reports grants from AstraZeneca, Bristol-Myers Squibb/Pfizer, GlaxoSmithKline, Merck & Co, Boehringer Ingelheim, and Roche Diagnostics; Personal fees from Abbott. Dr. Wallentin has a patent (EP2047275B1) licensed to Roche Diagnostics and a patent (US8951742B2) licensed to Roche Diagnostics. Dr. Eikelboom reports consulting/honoraria support from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol-Myer-Squibb, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, Pfizer, Janssen, Sanofi-Aventis, Servier and grant support from Astra-Zeneca, Bayer, Boehringer-Ingelheim, Bristol-Myer-Squibb, Glaxo-Smith-Kline, Pfizer, Janssen, Sanofi-Aventis. Dr. Connolly reports research support and honoraria for consulting and lectures from Portola, BMS, Pfizer, Javelin, Boehringer Ingelheim, Bayer, Daiichi Sankyo, and Abbott.